NSEBSE
There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.Open-
High-
Low-
Prev. Close-
Avg. Traded Price-
Volume-
MARKET DEPTH
Total bid0.00
Total ask0.00
HIGH/LOW
LOW/HIGH
₹318.152 days ago
₹324.952 days ago
Suraksha Diagnostic Limited was incorporated as ‘Suraksha Diagnostic Private Limited’ as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation dated March 15, 2005, issued by the Deputy Registrar of Companies, West Bengal at Kolkata (RoC). Subsequently, the company was converted into a public limited company pursuant to a special resolution passed in the extra-ordinary general meeting of its Shareholders held on June 5, 2024, and consequently, the name of the company was changed to ‘Suraksha Diagnostic Limited’, and a fresh certificate of incorporation dated July 16, 2024, was issued by the Registrar of Companies, Central Processing Centre.The company offers one-stop integrated solutions for pathology and radiology testing and medical consultation services including X-rays, ultrasonography, computerized tomography, magnetic resonance imaging scans and vaccination services through its operational network, consisting of its flagship central reference laboratory, 8 satellite laboratories (co-located with its diagnostic centers) and 215 customer touchpoints which include 49 diagnostic centres, and 166 sample collection centres (primarily franchised), as of June 30, 2024 across the states of West Bengal, Bihar, Assam, and Meghalaya. It generates revenue primarily through sales of its diagnostic services. It also provides vaccination services, and a broad spectrum of customized test packages, aimed at prediction/early detection of diseases.In addition to integrated pathology and radiology testing services, it also offers omnichannel medical consultation services via online and offline modes to its customers. The doctors at its polyclinics range across specialties and super-specialties such as cardiology, pediatrics, dermatology, rheumatology, oncology, and nephrology. Its model of polyclinic chambers housed in diagnostic centres providing medical consultation services enables patient convenience through holistic integration of services and offering it the first right to a patient’s prescription leading to higher cross-selling opportunities to the company. It derives the majority of its revenues from the B2C segment.Business area of the companyThe company is primarily engaged in the business of running diagnostic centres for carrying out various pathological and radiological services.Diagnostic services of the companyRoutine pathology testsSpecialized pathology testsBasic and intermediate radiology testsAdvanced radiology testsPreventive and wellness servicesAwards, accreditations, and recognition2017: Best quality in service delivery awarded by ABP News.2019: Best customer service in healthcare awarded by ABP News.2021: Business Leader of the Year organised by World Leadership Congress Awards and certificate of excellence at the Health Conclave 2021 organised by Zee24 Ghanta.2022: Awarded the outstanding diagnostic chain of eastern Indian by ABP Ananda.2023: Certificate of excellence in exemplary trust and commitment towards diagnostic services at the Health Conclave 2023 organised by Zee24 Ghanta.History and milestones2007: Launched the first centre of the Company at Kestopur, West Bengal.2010: Launched centre at Khardah, West Bengal and number of operating centres increased to 5.2013: Received first round of funding of Rs 300 million from private equity investor Lighthouse Funds, through their investment entity India 2020 Limited.2016: Number of laboratories increased to 4 and number of operating centres increased to 25.2016: Received second round of funding of Rs 200 million from OrbiMed Asia II Mauritius FDI Investments Limited (since amalgamated into OrbiMed Asia II Mauritius Limited), and also marked the exit of the India 2020 Limited from the Company.2017: Acquired the business of Sunwell Diagnostic Private Limited for a consideration of Rs 30 million.2019: Expansion of its operations to Meghalaya through a public-private partnership with the Government of Meghalaya.2020: Acquisition of 2 pre-existing diagnostic centres in Kolkata from Future Medical and Research Trust for a consideration of Rs 67 million.2023: Established its first 3T MRI and 128 CT at New Town.
